Liquidia (LQDA) EPS (Weighted Average and Diluted) (2020 - 2026)
Liquidia (LQDA) recorded quarterly EPS (Weighted Average and Diluted) of $0.52 in Q1 2026, up 205.88% quarter-over-quarter from $0.17 in Q4 2025, and up 215.56% on a YoY basis from $0.16 in Q1 2025.
Liquidia (LQDA) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Liquidia's EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at $0.52 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 215.56% year-over-year to $0.52; the TTM figure through Mar 2026 stood at $0.16 (up 109.47% YoY), while the FY2025 annual figure was -$0.8, up 50.92% from the prior year.
- EPS (Weighted Average and Diluted) was $0.52 for Q1 2026 at Liquidia, up from $0.17 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.52 in Q1 2026 to a low of -$0.49 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.22 across 5 years, with a median of -$0.3 in 2022.
- The sharpest annual moves came in 2023 and 2026: EPS (Weighted Average and Diluted) tumbled 366.67% in 2023, then surged 215.56% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.09 in 2022, then sank by 366.67% to -$0.42 in 2023, then fell by 9.52% to -$0.46 in 2024, then jumped by 136.96% to $0.17 in 2025, then soared by 205.88% to $0.52 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.52 (Q1 2026), $0.17 (Q4 2025), and -$0.04 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -0.40 |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.52 |
| Dec 31, 2025 | 0.17 |
| Sep 30, 2025 | -0.04 |
| Jun 30, 2025 | -0.49 |
| Mar 31, 2025 | -0.45 |
| Dec 31, 2024 | -0.46 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | -0.38 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.42 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -0.09 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | -0.15 |
| Mar 31, 2022 | -0.30 |
| Dec 31, 2021 | -0.23 |
| Sep 30, 2021 | -0.14 |
| Jun 30, 2021 | -0.13 |